SILENCE THERAPEUTICS PLC Share Price Today: Live Updates & Key Insights
SILENCE THERAPEUTICS PLC share price today is $6.17, up -3.29%. The stock opened at $6.367 against the previous close of $6.38, with an intraday high of $6.4 and low of $6.1.
SILENCE THERAPEUTICS PLC Share Price Chart
SILENCE THERAPEUTICS PLC
SILENCE THERAPEUTICS PLC Share Price Performance
SILENCE THERAPEUTICS PLC Institutional Holdings
SILENCE THERAPEUTICS PLC Market Status
SILENCE THERAPEUTICS PLC Fundamentals
Market Cap 291.43 M
PB Ratio 4.8292
PE Ratio 0.0
Enterprise Value 198.45 M
Total Assets 131.44 M
Volume 255130
SILENCE THERAPEUTICS PLC Company Financials
About SILENCE THERAPEUTICS PLC & investment objective
Company Information Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company develops Divesiran (SLN124), which is in Phase 2 development for polycythemia vera, and SLN548 for complement-mediated renal diseases. It also develops Zerlasiran (SLN360) for cardiovascular disease associated with elevated lipoprotein(a); SLN312 for dyslipidemia; SLN365 for hypercholesterolemia; and SLN098 for obesity. The company was formerly known as SR Pharma plc and changed its name to Silence Therapeutics plc in May 2007. Silence Therapeutics plc was incorporated in 1994 and is headquartered in London, United Kingdom.
Organisation Biotechnology
Employees 88
Industry Biotechnology
CEO Mr. Iain Gladstone Ross B.Sc., BSc (Hons), C.DIR, CH.D
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
SILENCE THERAPEUTICS PLC FAQs
What is the share price of SILENCE THERAPEUTICS PLC today?
The current share price of SILENCE THERAPEUTICS PLC is $6.17.
Can I buy SILENCE THERAPEUTICS PLC shares in India?
Yes, Indian investors can buy SILENCE THERAPEUTICS PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy SILENCE THERAPEUTICS PLC shares in India?
You can easily invest in SILENCE THERAPEUTICS PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy SILENCE THERAPEUTICS PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of SILENCE THERAPEUTICS PLC.
Can I buy fractional shares of SILENCE THERAPEUTICS PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of SILENCE THERAPEUTICS PLC?
SILENCE THERAPEUTICS PLC has a market cap of $291.43 M.
In which sector does SILENCE THERAPEUTICS PLC belong?
SILENCE THERAPEUTICS PLC operates in the Biotechnology sector.
What documents are required to invest in SILENCE THERAPEUTICS PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of SILENCE THERAPEUTICS PLC?
The PE ratio of SILENCE THERAPEUTICS PLC is N/A and the PB ratio is 4.83.